Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH) subsidiary received the pharmaceutical registration certificate from Macau.
White Cloud Mountain (600332.SH) announced that recently, its controlling subsidiary, Guangzhou White Cloud Mountain Tianxin Pharmaceutical Co., Ltd. (referred to as Tianxin Pharmaceutical), received the "Drug Registration Certificate" issued by the Macao Special Administrative Region Government's Health Bureau, for the drug name: Sodium Cefazolin for Injection (0.5g, 1.0g).
Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH) announced that its subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (referred to as Tianxin Pharmaceutical), recently received the "Drug Registration Certificate" issued by the Macao Special Administrative Region Governments Bureau of Pharmaceutical Supervision. The drug name: Sodium Cefazolin for Injection (0.5g, 1.0g).
This drug has passed the national consistency evaluation of quality and efficacy for generic drugs. With the issuance of the "Drug Registration Certificate" by the Macao Special Administrative Region Governments Bureau of Pharmaceutical Supervision, the drug will be authorized for sale in the Macao region by Tianxin Pharmaceutical through Guangzhou Pharmaceutical International (Macao) for drug product import and wholesale, which will help Tianxin Pharmaceutical expand its overseas market business and enhance the market competitiveness of the companys products.
Related Articles
TONGSHIFU (00664) issued a profit warning, expecting a mid-term net profit of 1 million to 1.5 million yuan, a year-on-year decrease.
SINOPHARM (01099): China National Accord Medicines Corporation's net profit attributable to shareholders in the first half of the year was 606 million yuan, a year-on-year decrease of 8.97%.
REDCO HEALTHY (02370) announces a positive profit alert, expecting a mid-term net profit not to exceed 2 million yuan, turning a profit compared to the same period last year.
TONGSHIFU (00664) issued a profit warning, expecting a mid-term net profit of 1 million to 1.5 million yuan, a year-on-year decrease.
SINOPHARM (01099): China National Accord Medicines Corporation's net profit attributable to shareholders in the first half of the year was 606 million yuan, a year-on-year decrease of 8.97%.
REDCO HEALTHY (02370) announces a positive profit alert, expecting a mid-term net profit not to exceed 2 million yuan, turning a profit compared to the same period last year.
RECOMMEND
